Natural killer cells in hepatitis C:Current progress
|
摘要
Patients infected with the hepatitis C virus(HCV) are characterized by a high incidence of chronic infection, which results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. The functional impairment of HCV-specific T cells is associated with the evolution of an acute infection to chronic hepatitis. While T cells are the important effector cells in adaptive immunity, natural killer(NK) cells are the critical effector cells in innate immunity to virus infections. The findings of recent studies on NK cells in hepatitis C suggest that NK cell responses are indeed important in each phase of HCV infection. In the early phase, NK cells are involved in protective immunity to HCV. The immune evasion strategies used by HCV may target NK cells and might contribute to the progression to chronic hepatitis C. NK cells may control HCV replication and modulate hepatic fibrosis in the chronic phase. Further investigations are, however, needed, because a considerable number of studies observed functional impairment of NK cells in chronic HCV infection. Interestingly, the enhanced NK cell responses during interferon-α-based therapy of chronic hepatitis C indicate successful treatment. In spite of the advances in research on NK cells in hepatitis C, establishment of more physiological HCV infection model systems is needed to settle unsolved controversies over the role and functional status of NK cells in HCV infection.
Patients infected with the hepatitis C virus(HCV) are characterized by a high incidence of chronic infection, which results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. The functional impairment of HCV-specific T cells is associated with the evolution of an acute infection to chronic hepatitis. While T cells are the important effector cells in adaptive immunity, natural killer(NK) cells are the critical effector cells in innate immunity to virus infections. The findings of recent studies on NK cells in hepatitis C suggest that NK cell responses are indeed important in each phase of HCV infection. In the early phase, NK cells are involved in protective immunity to HCV. The immune evasion strategies used by HCV may target NK cells and might contribute to the progression to chronic hepatitis C. NK cells may control HCV replication and modulate hepatic fibrosis in the chronic phase. Further investigations are, however, needed, because a considerable number of studies observed functional impairment of NK cells in chronic HCV infection. Interestingly, the enhanced NK cell responses during interferon-α-based therapy of chronic hepatitis C indicate successful treatment. In spite of the advances in research on NK cells in hepatitis C, establishment of more physiological HCV infection model systems is needed to settle unsolved controversies over the role and functional status of NK cells in HCV infection.
Patients infected with the hepatitis C virus(HCV) are characterized by a high incidence of chronic infection, which results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. The functional impairment of HCV-specific T cells is associated with the evolution of an acute infection to chronic hepatitis. While T cells are the important effector cells in adaptive immunity, natural killer(NK) cells are the critical effector cells in innate immunity to virus infections. The findings of recent studies on NK cells in hepatitis C suggest that NK cell responses are indeed important in each phase of HCV infection. In the early phase, NK cells are involved in protective immunity to HCV. The immune evasion strategies used by HCV may target NK cells and might contribute to the progression to chronic hepatitis C. NK cells may control HCV replication and modulate hepatic fibrosis in the chronic phase. Further investigations are, however, needed, because a considerable number of studies observed functional impairment of NK cells in chronic HCV infection. Interestingly, the enhanced NK cell responses during interferon-α-based therapy of chronic hepatitis C indicate successful treatment. In spite of the advances in research on NK cells in hepatitis C, establishment of more physiological HCV infection model systems is needed to settle unsolved controversies over the role and functional status of NK cells in HCV infection.
引文
1 Hoofnagle JH.Course and outcome of hepatitis C.Hepatology 2002;36:S21-S29[PMID:12407573 DOI:10.1053/jhep.2002.36227]
2 Rehermann B.Hepatitis C virus versus innate and adaptive immune responses:a tale of coevolution and coexistence.J Clin Invest 2009;119:1745-1754[PMID:19587449 DOI:10.1172/JCI39133]
3 Lee MH,Yang HI,Yuan Y,L’Italien G,Chen CJ.Epidemiology and natural history of hepatitis C virus infection.World JGastroenterol 2014;20:9270-9280[PMID:25071320 DOI:10.3748/wjg.v20.i28.9270]
4 Burra P.Hepatitis C.Semin Liver Dis 2009;29:53-65[PMID:19235659 DOI:10.1055/s-0029-1192055]
5 Dustin LB,Rice CM.Flying under the radar:the immunobiology of hepatitis C.Annu Rev Immunol 2007;25:71-99[PMID:17067278 DOI:10.1146/annurev.immunol.25.022106.141602]
6 Ferrari C.T and B cells in hepatitis C virus control:what they do and when they fail.Gastroenterology 2007;132:801-805[PMID:17261303 DOI:10.1053/j.gastro.2007.01.010]
7 Rehermann B.Chronic infections with hepatotropic viruses:mechanisms of impairment of cellular immune responses.Semin Liver Dis 2007;27:152-160[PMID:17520515 DOI:10.1055/s-2007-979468]
8 Rehermann B,Nascimbeni M.Immunology of hepatitis B virus and hepatitis C virus infection.Nat Rev Immunol 2005;5:215-229[PMID:15738952 DOI:10.1038/nri1573]
9 Ahlenstiel G.The natural killer cell response to HCV infection.Immune Netw 2013;13:168-176[PMID:24198741 DOI:10.4110/in.2013.13.5.168]
10 Abdel-Hakeem MS,Shoukry NH.Protective immunity against hepatitis C:many shades of gray.Front Immunol 2014;5:274[PMID:24982656 DOI:10.3389/fimmu.2014.00274]
11 Park SH,Rehermann B.Immune responses to HCV and other hepatitis viruses.Immunity 2014;40:13-24[PMID:24439265DOI:10.1016/j.immuni.2013.12.010]
12 Rehermann B.Pathogenesis of chronic viral hepatitis:differential roles of T cells and NK cells.Nat Med 2013;19:859-868[PMID:23836236 DOI:10.1038/nm.3251]
13 Mondelli MU,Varchetta S,Oliviero B.Natural killer cells in viral hepatitis:facts and controversies.Eur J Clin Invest 2010;40:851-863[PMID:20597961 DOI:10.1111/j.1365-2362.2010.02332.x]
14 Golden-Mason L,Rosen HR.Natural killer cells:multifaceted players with key roles in hepatitis C immunity.Immunol Rev 2013;255:68-81[PMID:23947348 DOI:10.1111/imr.12090]
15 Moradpour D,Penin F,Rice CM.Replication of hepatitis C virus.Nat Rev Microbiol 2007;5:453-463[PMID:17487147 DOI:nrmicro1645]
16 Scheel TK,Rice CM.Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Nat Med 2013;19:837-849[PMID:23836234 DOI:10.1038/nm.3248]
17 Herberman RB,Nunn ME,Lavrin DH.Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors.I.Distribution of reactivity and specificity.Int JCancer 1975;16:216-229[PMID:50294]
18 Kiessling R,Klein E,Wigzell H.“Natural”killer cells in the mouse.I.Cytotoxic cells with specificity for mouse Moloney leukemia cells.Specificity and distribution according to genotype.Eur J Immunol 1975;5:112-117[PMID:1234049 DOI:10.1002/eji.1830050208]
19 Vivier E,Raulet DH,Moretta A,Caligiuri MA,Zitvogel L,Lanier LL,Yokoyama WM,Ugolini S.Innate or adaptive immunity?The example of natural killer cells.Science 2011;331:44-49[PMID:21212348 DOI:10.1126/science.1198687]
20 Lanier LL.Evolutionary struggles between NK cells and viruses.Nat Rev Immunol 2008;8:259-268[PMID:18340344 DOI:nri2276]
21 Altfeld M,Fadda L,Frleta D,Bhardwaj N.DCs and NK cells:critical effectors in the immune response to HIV-1.Nat Rev Immunol 2011;11:176-186[PMID:21350578 DOI:10.1038/nri2935]
22 Caligiuri MA.Human natural killer cells.Blood 2008;112:461-469[PMID:18650461 DOI:112/3/461]
23 Lodoen MB,Lanier LL.Natural killer cells as an initial defense against pathogens.Curr Opin Immunol 2006;18:391-398[PMID:16765573]
24 Lee SH,Miyagi T,Biron CA.Keeping NK cells in highly regulated antiviral warfare.Trends Immunol 2007;28:252-259[PMID:17466596 DOI:10.1016/j.it.2007.04.001]
25 Lanier LL.Up on the tightrope:natural killer cell activation and inhibition.Nat Immunol 2008;9:495-502[PMID:18425106 DOI:ni1581]
26 Lanier LL.NK cell recognition.Annu Rev Immunol 2005;2 3:2 2 5-2 7 4[P M I D:1 5 7 7 1 5 7 1 D O I:1 0.11 4 6/a n n u r e v.immunol.23.021704.115526]
27 Vivier E,Tomasello E,Baratin M,Walzer T,Ugolini S.Functions of natural killer cells.Nat Immunol 2008;9:503-510[PMID:18425107 DOI:ni1582]
28 Cooper MA,Fehniger TA,Caligiuri MA.The biology of human natural killer-cell subsets.Trends Immunol 2001;22:633-640[PMID:11698225 DOI:S1471-4906(01)02060-9]
29 Cooper MA,Fehniger TA,Turner SC,Chen KS,Ghaheri BA,Ghayur T,Carson WE,Caligiuri MA.Human natural killer cells:a unique innate immunoregulatory role for the CD56(bright)subset.Blood 2001;97:3146-3151[PMID:11342442]
30 Doherty DG,O’Farrelly C.Innate and adaptive lymphoid cells in the human liver.Immunol Rev 2000;174:5-20[PMID:10807503]
31 Gao B,Radaeva S,Park O.Liver natural killer and natural killer T cells:immunobiology and emerging roles in liver diseases.J Leukoc Biol 2009;86:513-528[PMID:19542050 DOI:JLB.0309135]
32 Bonorino P,Ramzan M,Camous X,Dufeu-Duchesne T,Thélu MA,Sturm N,Dariz A,Guillermet C,Pernollet M,Zarski JP,Marche PN,Leroy V,Jouvin-Marche E.Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.J Hepatol 2009;51:458-467[PMID:19596474DOI:10.1016/j.jhep.2009.05.030]
33 Morishima C,Paschal DM,Wang CC,Yoshihara CS,Wood BL,Yeo AE,Emerson SS,Shuhart MC,Gretch DR.Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing.Hepatology 2006;43:573-580[PMID:16496327 DOI:10.1002/hep.21073]
34 Oliviero B,Varchetta S,Paudice E,Michelone G,Zaramella M,Mavilio D,De Filippi F,Bruno S,Mondelli MU.Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis Cvirus infections.Gastroenterology 2009;137:1151-160,1151-160,[PMID:19470388 DOI:10.1053/j.gastro.2009.05.047]
35 Grégoire C,Chasson L,Luci C,Tomasello E,Geissmann F,Vivier E,Walzer T.The trafficking of natural killer cells.Immunol Rev 2007;220:169-182[PMID:17979846 DOI:10.1111/j.1600-065X.2007.00563.x]
36 Golden-Mason L,Rosen HR.Natural killer cells:primary target for hepatitis C virus immune evasion strategies?Liver Transpl2006;12:363-372[PMID:16498647 DOI:10.1002/lt.20708]
37 Crotta S,Stilla A,Wack A,D’Andrea A,Nuti S,D’Oro U,Mosca M,Filliponi F,Brunetto RM,Bonino F,Abrignani S,Valiante NM.Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.J Exp Med 2002;195:35-41[PMID:11781363]
38 Tseng CT,Klimpel GR.Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.J Exp Med2002;195:43-49[PMID:11781364]
39 Herzer K,Falk CS,Encke J,Eichhorst ST,Ulsenheimer A,Seliger B,Krammer PH.Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.J Virol 2003;77:8299-8309[PMID:12857899]
40 Tardif KD,Siddiqui A.Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells.J Virol 2003;77:11644-11650[PMID:14557650]
41 Moradpour D,Grabscheid B,Kammer AR,Schmidtke G,Groettrup M,Blum HE,Cerny A.Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.Hepatology 2001;33:1282-1287[PMID:11343257 DOI:S0270-9139(01)30790-5]
42 Yang DR,Zhu HZ.Hepatitis C virus and antiviral innate immunity:who wins at tug-of-war?World J Gastroenterol 2015;21:3786-3800[PMID:25852264 DOI:10.3748/wjg.v21.i13.3786]
43 Billerbeck E,de Jong Y,Dorner M,de la Fuente C,Ploss A.Animal models for hepatitis C.Curr Top Microbiol Immunol 2013;369:49-86[PMID:23463197 DOI:10.1007/978-3-642-27340-7_3]
44 Lindenbach BD,Evans MJ,Syder AJ,W?lk B,Tellinghuisen TL,Liu CC,Maruyama T,Hynes RO,Burton DR,Mc Keating JA,Rice CM.Complete replication of hepatitis C virus in cell culture.Science 2005;309:623-626[PMID:15947137]
45 Wakita T,Pietschmann T,Kato T,Date T,Miyamoto M,Zhao Z,Murthy K,Habermann A,Kr?usslich HG,Mizokami M,Bartenschlager R,Liang TJ.Production of infectious hepatitis Cvirus in tissue culture from a cloned viral genome.Nat Med 2005;11:791-796[PMID:15951748]
46 Zhong J,Gastaminza P,Cheng G,Kapadia S,Kato T,Burton DR,Wieland SF,Uprichard SL,Wakita T,Chisari FV.Robust hepatitis C virus infection in vitro.Proc Natl Acad Sci USA 2005;102:9294-9299[PMID:15939869]
47 Crotta S,Brazzoli M,Piccioli D,Valiante NM,Wack A.Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.J Hepatol 2010;52:183-190[PMID:20015567]
48 Yoon JC,Shiina M,Ahlenstiel G,Rehermann B.Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.Hepatology 2009;49:12-21[PMID:19085909 DOI:10.1002/hep.22624]
49 Yoon JC,Lim JB,Park JH,Lee JM.Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.J Virol 2011;85:12557-12569[PMID:21937646 DOI:10.1128/JVI.00838-11]
50 Holder KA,Stapleton SN,Gallant ME,Russell RS,Grant MD.Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.J Immunol 2013;191:3308-3318[PMID:23960237 DOI:10.4049/jimmunol.1300164]
51 Stegmann KA,Bj?rkstr?m NK,Ciesek S,Lunemann S,Jaroszewicz J,Wiegand J,Malinski P,Dustin LB,Rice CM,Manns MP,Pietschmann T,Cornberg M,Ljunggren HG,Wedemeyer H.Interferonα-stimulated natural killer cells from patients with acute hepatitis C virus(HCV)infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.JInfect Dis 2012;205:1351-1362[PMID:22457290 DOI:10.1093/infdis/jis210]
52 Stegmann KA,Bj?rkstr?m NK,Veber H,Ciesek S,Riese P,Wiegand J,Hadem J,Suneetha PV,Jaroszewicz J,Wang C,Schlaphoff V,Fytili P,Cornberg M,Manns MP,Geffers R,Pietschmann T,Guzmán CA,Ljunggren HG,Wedemeyer H.Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.Gastroenterology2010;138:1885-1897[PMID:20334827 DOI:10.1053/j.gastro.2010.01.051]
53 Biron CA,Nguyen KB,Pien GC,Cousens LP,Salazar-Mather TP.Natural killer cells in antiviral defense:function and regulation by innate cytokines.Annu Rev Immunol 1999;17:189-220[PMID:10358757 DOI:10.1146/annurev.immunol.17.1.189]
54 Hart OM,Athie-Morales V,O’Connor GM,Gardiner CM.TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.J Immunol 2005;175:1636-1642[PMID:16034103]
55 Newman KC,Riley EM.Whatever turns you on:accessory-celldependent activation of NK cells by pathogens.Nat Rev Immunol2007;7:279-291[PMID:17380157 DOI:10.1038/nri2057]
56 Cooper MA,Fehniger TA,Fuchs A,Colonna M,Caligiuri MA.NK cell and DC interactions.Trends Immunol 2004;25:47-52[PMID:14698284]
57 Velazquez VM,Hon H,Ibegbu C,Knechtle SJ,Kirk AD,Grakoui A.Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.Hepatology 2012;56:2071-2081[PMID:22711645 DOI:10.1002/hep.25904]
58 Michel T,Hentges F,Zimmer J.Consequences of the crosstalk between monocytes/macrophages and natural killer cells.Front Immunol 2012;3:403[PMID:23316194 DOI:10.3389/fimmu.2012.00403]
59 Lau DT,Negash A,Chen J,Crochet N,Sinha M,Zhang Y,Guedj J,Holder S,Saito T,Lemon SM,Luxon BA,Perelson AS,Gale M.Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype1 infection.Gastroenterology 2013;144:402-413.e12[PMID:23123437 DOI:10.1053/j.gastro.2012.10.044]
60 Tu Z,Bozorgzadeh A,Pierce RH,Kurtis J,Crispe IN,Orloff MS.TLR-dependent cross talk between human Kupffer cells and NKcells.J Exp Med 2008;205:233-244[PMID:18195076 DOI:10.1084/jem.20072195]
61 Zhang S,Saha B,Kodys K,Szabo G.IFN-γproduction by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.J Hepatol 2013;59:442-449[PMID:23665181 DOI:10.1016/j.jhep.2013.04.022]
62 Marukian S,Jones CT,Andrus L,Evans MJ,Ritola KD,Charles ED,Rice CM,Dustin LB.Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.Hepatology2008;48:1843-1850[PMID:19003912 DOI:10.1002/hep.22550]
63 Dental C,Florentin J,Aouar B,Gondois-Rey F,Durantel D,Baumert TF,Nunes JA,Olive D,Hirsch I,Stranska R.Hepatitis Cvirus fails to activate NF-κB signaling in plasmacytoid dendritic cells.J Virol 2012;86:1090-1096[PMID:22090103 DOI:10.1128/JVI.05444-11]
64 Takahashi K,Asabe S,Wieland S,Garaigorta U,Gastaminza P,Isogawa M,Chisari FV.Plasmacytoid dendritic cells sense hepatitis C virus-infected cells,produce interferon,and inhibit infection.Proc Natl Acad Sci USA 2010;107:7431-7436[PMID:20231459DOI:10.1073/pnas.1002301107]
65 Zhang XA,Huang C.Tetraspanins and cell membrane tubular structures.Cell Mol Life Sci 2012;69:2843-2852[PMID:22450717 DOI:10.1007/s00018-012-0954-0]
66 Dreux M,Garaigorta U,Boyd B,Décembre E,Chung J,WhittenBauer C,Wieland S,Chisari FV.Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.Cell Host Microbe 2012;12:558-570[PMID:23084922 DOI:10.1016/j.chom.2012.08.010]
67 Serti E,Werner JM,Chattergoon M,Cox AL,Lohmann V,Rehermann B.Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis Cvirus replication.Gastroenterology 2014;147:209-220.e3[PMID:24685721 DOI:10.1053/j.gastro.2014.03.046]
68 Sène D,Levasseur F,Abel M,Lambert M,Camous X,Hernandez C,Pène V,Rosenberg AR,Jouvin-Marche E,Marche PN,Cacoub P,Caillat-Zucman S.Hepatitis C virus(HCV)evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.PLo S Pathog 2010;6:e1001184[PMID:21085608 DOI:10.1371/journal.ppat.1001184]
69 Khakoo SI,Thio CL,Martin MP,Brooks CR,Gao X,Astemborski J,Cheng J,Goedert JJ,Vlahov D,Hilgartner M,Cox S,Little AM,Alexander GJ,Cramp ME,O’Brien SJ,Rosenberg WM,Thomas DL,Carrington M.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.Science 2004;305:872-874[PMID:15297676 DOI:10.1126/science.1097670]
70 Cheent K,Khakoo SI.Natural killer cells and hepatitis C:action and reaction.Gut 2011;60:268-278[PMID:20876777 DOI:10.1136/gut.2010.212555]
71 Bengsch B,Thimme R,Blum HE.Role of host genetic factors in the outcome of hepatitis C virus infection.Viruses 2009;1:104-125[PMID:21994541 DOI:10.3390/v1020104]
72 Ahlenstiel G,Martin MP,Gao X,Carrington M,Rehermann B.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.J Clin Invest 2008;118:1017-1026[PMID:18246204 DOI:10.1172/JCI32400]
73 Amadei B,Urbani S,Cazaly A,Fisicaro P,Zerbini A,Ahmed P,Missale G,Ferrari C,Khakoo SI.Activation of natural killer cells during acute infection with hepatitis C virus.Gastroenterology2010;138:1536-1545[PMID:20080094 DOI:10.1053/j.gastro.2010.01.006]
74 Werner JM,Heller T,Gordon AM,Sheets A,Sherker AH,Kessler E,Bean KS,Stevens M,Schmitt J,Rehermann B.Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.Hepatology 2013;58:1621-1631[PMID:23463364 DOI:10.1002/hep.26353]
75 Pelletier S,Drouin C,Bédard N,Khakoo SI,Bruneau J,Shoukry NH.Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.J Hepatol 2010;53:805-816[PMID:20688412 DOI:10.1016/j.jhep.2010.05.013]
76 Kokordelis P,Kr?mer B,K?rner C,Boesecke C,Voigt E,Ingiliz P,Gl?ssner A,Eisenhardt M,Wolter F,Kaczmarek D,Nischalke HD,Rockstroh JK,Spengler U,Nattermann J.An effective interferongamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.Hepatology 2014;59:814-827[PMID:24382664 DOI:10.1002/hep.26782]
77 Ahlenstiel G,Titerence RH,Koh C,Edlich B,Feld JJ,Rotman Y,Ghany MG,Hoofnagle JH,Liang TJ,Heller T,Rehermann B.Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.Gastroenterology 2010;138:325-35.e1-2[PMID:19747917 DOI:10.1053/j.gastro.2009.08.066]
78 Golden-Mason L,Madrigal-Estebas L,Mc Grath E,Conroy MJ,Ryan EJ,Hegarty JE,O’Farrelly C,Doherty DG.Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.Gut 2008;57:1121-1128[PMID:18372499 DOI:10.1136/gut.2007.130963]
79 Jinushi M,Takehara T,Tatsumi T,Kanto T,Miyagi T,Suzuki T,Kanazawa Y,Hiramatsu N,Hayashi N.Negative regulation of NKcell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.J Immunol 2004;173:6072-6081[PMID:15528343]
80 Nattermann J,Feldmann G,Ahlenstiel G,Langhans B,Sauerbruch T,Spengler U.Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.Gut 2006;55:869-877[PMID:16322112 DOI:10.1136/gut.2005.076463]
81 Edlich B,Ahlenstiel G,Zabaleta Azpiroz A,Stoltzfus J,Noureddin M,Serti E,Feld JJ,Liang TJ,Rotman Y,Rehermann B.Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis Cpatients.Hepatology 2012;55:39-48[PMID:21898483 DOI:10.1002/hep.24628]
82 Miyagi T,Gil MP,Wang X,Louten J,Chu WM,Biron CA.High basal STAT4 balanced by STAT1 induction to control type1 interferon effects in natural killer cells.J Exp Med 2007;204:2383-2396[PMID:17846149 DOI:10.1084/jem.20070401]
83 Miyagi T,Takehara T,Nishio K,Shimizu S,Kohga K,Li W,Tatsumi T,Hiramatsu N,Kanto T,Hayashi N.Altered interferonalpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.J Hepatol 2010;53:424-430[PMID:20554341 DOI:10.1016/j.jhep.2010.03.018]
84 Nguyen KB,Cousens LP,Doughty LA,Pien GC,Durbin JE,Biron CA.Interferon alpha/beta-mediated inhibition and promotion of interferon gamma:STAT1 resolves a paradox.Nat Immunol 2000;1:70-76[PMID:10881178 DOI:10.1038/76940]
85 Kr?mer B,K?rner C,Kebschull M,Gl?ssner A,Eisenhardt M,Nischalke HD,Alexander M,Sauerbruch T,Spengler U,Nattermann J.Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.Hepatology2012;56:1201-1213[PMID:22532190 DOI:10.1002/hep.25804]
86 Gl?ssner A,Eisenhardt M,Kr?mer B,K?rner C,Coenen M,Sauerbruch T,Spengler U,Nattermann J.NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-,Fas L-and NKG2D-dependent manner.Lab Invest 2012;92:967-977[PMID:22449797 DOI:10.1038/labinvest.2012.54]
87 Pembroke T,Christian A,Jones E,Hills RK,Wang EC,Gallimore AM,Godkin A.The paradox of NKp46+natural killer cells:drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferonαtreatment.Gut 2014;63:515-524[PMID:23665989 DOI:10.1136/gutjnl-2013-304472]
88 De Maria A,Fogli M,Mazza S,Basso M,Picciotto A,Costa P,Congia S,Mingari MC,Moretta L.Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.Eur J Immunol 2007;37:445-455[PMID:17273991 DOI:10.1002/eji.200635989]
89 Varchetta S,Mele D,Mantovani S,Oliviero B,Cremonesi E,Ludovisi S,Michelone G,Alessiani M,Rosati R,Montorsi M,Mondelli MU.Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.Hepatology 2012;56:841-849[PMID:22431186 DOI:10.1002/hep.25723]
90 Wang JM,Cheng YQ,Shi L,Ying RS,Wu XY,Li GY,Moorman JP,Yao ZQ.KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.J Virol 2013;87:11626-11636[PMID:23966413 DOI:10.1128/JVI.01515-13]
91 Gonzalez VD,Landay AL,Sandberg JK.Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.Clin Immunol 2010;135:12-25[PMID:20100670 DOI:10.1016/j.clim.2009.12.005]
92 Hernandez MD,Sherman KE.HIV/hepatitis C coinfection natural history and disease progression.Curr Opin HIVAIDS 2011;6:478-482[PMID:22001892 DOI:10.1097/COH.0b013e32834bd365]
93 Gl?ssner A,Eisenhardt M,Kokordelis P,Kr?mer B,Wolter F,Nischalke HD,Boesecke C,Sauerbruch T,Rockstroh JK,Spengler U,Nattermann J.Impaired CD4?T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.J Hepatol 2013;59:427-433[PMID:23665286 DOI:10.1016/j.jhep.2013.04.029]
94 Knapp S,Warshow U,Hegazy D,Brackenbury L,Guha IN,Fowell A,Little AM,Alexander GJ,Rosenberg WM,Cramp ME,Khakoo SI.Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.Hepatology2010;51:1168-1175[PMID:20077564 DOI:10.1002/hep.23477]
95 Suppiah V,Gaudieri S,Armstrong NJ,O’Connor KS,Berg T,Weltman M,Abate ML,Spengler U,Bassendine M,Dore GJ,Irving WL,Powell E,Hellard M,Riordan S,Matthews G,Sheridan D,Nattermann J,Smedile A,Müller T,Hammond E,Dunn D,Negro F,Bochud PY,Mallal S,Ahlenstiel G,Stewart GJ,George J,Booth DR.IL28B,HLA-C,and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort:a cross-sectional study.PLo SMed 2011;8:e1001092[PMID:21931540 DOI:10.1371/journal.pmed.1001092]
96 Kaser A,Enrich B,Ludwiczek O,Vogel W,Tilg H.Interferonalpha(IFN-alpha)enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.Clin Exp Immunol 1999;118:71-77[PMID:10540162]
97 Bozzano F,Picciotto A,Costa P,Marras F,Fazio V,Hirsch I,Olive D,Moretta L,De Maria A.Activating NK cell receptor expression/function(NKp30,NKp46,DNAM-1)during chronic viraemic HCV infection is associated with the outcome of combined treatment.Eur J Immunol 2011;41:2905-2914[PMID:21695691DOI:10.1002/eji.201041361]
98 Conry SJ,Meng Q,Hardy G,Yonkers NL,Sugalski JM,Hirsch A,Davitkov P,Compan A,Falck-Ytter Y,Blanton RE,Rodriguez B,Harding CV,Anthony DD.Genetically associated CD16(+)56(-)natural killer cell interferon(IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.J Infect Dis 2012;205:1131-1141[PMID:22351942 DOI:10.1093/infdis/jis027]
99 Ahlenstiel G,Edlich B,Hogdal LJ,Rotman Y,Noureddin M,Feld JJ,Holz LE,Titerence RH,Liang TJ,Rehermann B.Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.Gastroenterology 2011;141:1231-1239[PMID:21741920 DOI:10.1053/j.gastro.2011.06.069]
100 Oliviero B,Mele D,Degasperi E,Aghemo A,Cremonesi E,Rumi MG,Tinelli C,Varchetta S,Mantovani S,Colombo M,Mondelli MU.Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.J Hepatol 2013;59:38-44[PMID:23499727 DOI:10.1016/j.jhep.2013.03.003]
101 He XS,Ji X,Hale MB,Cheung R,Ahmed A,Guo Y,Nolan GP,Pfeffer LM,Wright TL,Risch N,Tibshirani R,Greenberg HB.Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.Hepatology2006;44:352-359[PMID:16871572 DOI:10.1002/hep.21267]
102 Sarasin-Filipowicz M,Oakeley EJ,Duong FH,Christen V,Terracciano L,Filipowicz W,Heim MH.Interferon signaling and treatment outcome in chronic hepatitis C.Proc Natl Acad Sci USA 2008;105:7034-7039[PMID:18467494 DOI:10.1073/pnas.0707882105]
103 Ge D,Fellay J,Thompson AJ,Simon JS,Shianna KV,Urban TJ,Heinzen EL,Qiu P,Bertelsen AH,Muir AJ,Sulkowski M,Mc Hutchison JG,Goldstein DB.Genetic variation in IL28Bpredicts hepatitis C treatment-induced viral clearance.Nature2009;461:399-401[PMID:19684573 DOI:10.1038/nature08309]
104 Suppiah V,Moldovan M,Ahlenstiel G,Berg T,Weltman M,Abate ML,Bassendine M,Spengler U,Dore GJ,Powell E,Riordan S,Sheridan D,Smedile A,Fragomeli V,Müller T,Bahlo M,Stewart GJ,Booth DR,George J.IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.Nat Genet 2009;41:1100-1104[PMID:19749758 DOI:10.1038/ng.447]
105 Tanaka Y,Nishida N,Sugiyama M,Kurosaki M,Matsuura K,Sakamoto N,Nakagawa M,Korenaga M,Hino K,Hige S,Ito Y,Mita E,Tanaka E,Mochida S,Murawaki Y,Honda M,Sakai A,Hiasa Y,Nishiguchi S,Koike A,Sakaida I,Imamura M,Ito K,Yano K,Masaki N,Sugauchi F,Izumi N,Tokunaga K,Mizokami M.Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.Nat Genet 2009;41:1105-1109[PMID:19749757 DOI:10.1038/ng.449]
106 Naggie S,Osinusi A,Katsounas A,Lempicki R,Herrmann E,Thompson AJ,Clark PJ,Patel K,Muir AJ,Mc Hutchison JG,Schlaak JF,Trippler M,Shivakumar B,Masur H,Polis MA,Kottilil S.Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients:impaired viral kinetics and therapeutic response.Hepatology 2012;56:444-454[PMID:22331604 DOI:10.1002/hep.25647]
107 Golden-Mason L,Bambha KM,Cheng L,Howell CD,Taylor MW,Clark PJ,Afdhal N,Rosen HR.Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C.Hepatology 2011;54:1559-1569[PMID:21983945 DOI:10.1002/hep.24556]
108 Kr?mer B,Eisenhardt M,Gl?ssner A,K?rner C,Sauerbruch T,Spengler U,Nattermann J.Do lambda-IFNs IL28A and IL28Bact on human natural killer cells?Proc Natl Acad Sci USA 2011;108:E519-E520;author reply E521-E522[PMID:21825163 DOI:10.1073/pnas.1108850108]
109 O’Connor KS,Ahlenstiel G,Suppiah V,Schibeci S,Ong A,Leung R,van der Poorten D,Douglas MW,Weltman MD,Stewart GJ,Liddle C,George J,Booth DR.IFNL3 mediates interaction between innate immune cells:Implications for hepatitis C virus pathogenesis.Innate Immun 2014;20:598-605[PMID:24045339DOI:10.1177/1753425913503385]
110 Dring MM,Morrison MH,Mc Sharry BP,Guinan KJ,Hagan R,O’Farrelly C,Gardiner CM.Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.Proc Natl Acad Sci USA 2011;108:5736-5741[PMID:21402922 DOI:10.1073/pnas.1016358108]
111 Shimoda S,Sumida K,Iwasaka S,Hisamoto S,Tanimoto H,Nomura H,Dohmen K,Takahashi K,Kawano A,Ogawa E,Furusyo N,Akashi K,Hayashi J.Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections.Hepat Res Treat 2013;2013:374196[PMID:23997950 DOI:10.1155/2013/374196]
112 Anthony DD,Conry SJ,Medvik K,Sandhya Rani MR,FalckYtter Y,Blanton RE,Lederman MM,Rodriguez B,Landay AL,Sandberg JK.Baseline levels of soluble CD14 and CD16+56-natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.JInfect Dis 2012;206:969-973[PMID:22782948 DOI:10.1093/infdis/jis434]
113 Serti E,Chepa-Lotrea X,Kim YJ,Keane M,Fryzek N,Liang TJ,Ghany M,Rehermann B.Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.Gastroenterology 2015;149:190-200.e2[PMID:25754160 DOI:10.1053/j.gastro.2015.03.004]
114 Kolykhalov AA,Agapov EV,Blight KJ,Mihalik K,Feinstone SM,Rice CM.Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.Science 1997;277:570-574[PMID:9228008]
115 Lindenbach BD,Meuleman P,Ploss A,Vanwolleghem T,Syder AJ,Mc Keating JA,Lanford RE,Feinstone SM,Major ME,Leroux-Roels G,Rice CM.Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.Proc Natl Acad Sci USA 2006;103:3805-3809[PMID:16484368 DOI:10.1073/pnas.0511218103]
116 Farquhar MJ,Mc Keating JA.Primary hepatocytes as targets for hepatitis C virus replication.J Viral Hepat 2008;15:849-854[PMID:19087224 DOI:JVH1051]
117 Wieland S,Makowska Z,Campana B,Calabrese D,Dill MT,Chung J,Chisari FV,Heim MH.Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver.Hepatology 2014;59:2121-2130[PMID:24122862 DOI:10.1002/hep.26770]
118 Dorner M,Horwitz JA,Robbins JB,Barry WT,Feng Q,Mu K,Jones CT,Schoggins JW,Catanese MT,Burton DR,Law M,Rice CM,Ploss A.A genetically humanized mouse model for hepatitis C virus infection.Nature 2011;474:208-211[PMID:21654804]
119 Dorner M,Ploss A.Deconstructing hepatitis C virus infection in humanized mice.Ann N Y Acad Sci 2011;1245:59-62[PMID:22211981]
2 Rehermann B.Hepatitis C virus versus innate and adaptive immune responses:a tale of coevolution and coexistence.J Clin Invest 2009;119:1745-1754[PMID:19587449 DOI:10.1172/JCI39133]
3 Lee MH,Yang HI,Yuan Y,L’Italien G,Chen CJ.Epidemiology and natural history of hepatitis C virus infection.World JGastroenterol 2014;20:9270-9280[PMID:25071320 DOI:10.3748/wjg.v20.i28.9270]
4 Burra P.Hepatitis C.Semin Liver Dis 2009;29:53-65[PMID:19235659 DOI:10.1055/s-0029-1192055]
5 Dustin LB,Rice CM.Flying under the radar:the immunobiology of hepatitis C.Annu Rev Immunol 2007;25:71-99[PMID:17067278 DOI:10.1146/annurev.immunol.25.022106.141602]
6 Ferrari C.T and B cells in hepatitis C virus control:what they do and when they fail.Gastroenterology 2007;132:801-805[PMID:17261303 DOI:10.1053/j.gastro.2007.01.010]
7 Rehermann B.Chronic infections with hepatotropic viruses:mechanisms of impairment of cellular immune responses.Semin Liver Dis 2007;27:152-160[PMID:17520515 DOI:10.1055/s-2007-979468]
8 Rehermann B,Nascimbeni M.Immunology of hepatitis B virus and hepatitis C virus infection.Nat Rev Immunol 2005;5:215-229[PMID:15738952 DOI:10.1038/nri1573]
9 Ahlenstiel G.The natural killer cell response to HCV infection.Immune Netw 2013;13:168-176[PMID:24198741 DOI:10.4110/in.2013.13.5.168]
10 Abdel-Hakeem MS,Shoukry NH.Protective immunity against hepatitis C:many shades of gray.Front Immunol 2014;5:274[PMID:24982656 DOI:10.3389/fimmu.2014.00274]
11 Park SH,Rehermann B.Immune responses to HCV and other hepatitis viruses.Immunity 2014;40:13-24[PMID:24439265DOI:10.1016/j.immuni.2013.12.010]
12 Rehermann B.Pathogenesis of chronic viral hepatitis:differential roles of T cells and NK cells.Nat Med 2013;19:859-868[PMID:23836236 DOI:10.1038/nm.3251]
13 Mondelli MU,Varchetta S,Oliviero B.Natural killer cells in viral hepatitis:facts and controversies.Eur J Clin Invest 2010;40:851-863[PMID:20597961 DOI:10.1111/j.1365-2362.2010.02332.x]
14 Golden-Mason L,Rosen HR.Natural killer cells:multifaceted players with key roles in hepatitis C immunity.Immunol Rev 2013;255:68-81[PMID:23947348 DOI:10.1111/imr.12090]
15 Moradpour D,Penin F,Rice CM.Replication of hepatitis C virus.Nat Rev Microbiol 2007;5:453-463[PMID:17487147 DOI:nrmicro1645]
16 Scheel TK,Rice CM.Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Nat Med 2013;19:837-849[PMID:23836234 DOI:10.1038/nm.3248]
17 Herberman RB,Nunn ME,Lavrin DH.Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors.I.Distribution of reactivity and specificity.Int JCancer 1975;16:216-229[PMID:50294]
18 Kiessling R,Klein E,Wigzell H.“Natural”killer cells in the mouse.I.Cytotoxic cells with specificity for mouse Moloney leukemia cells.Specificity and distribution according to genotype.Eur J Immunol 1975;5:112-117[PMID:1234049 DOI:10.1002/eji.1830050208]
19 Vivier E,Raulet DH,Moretta A,Caligiuri MA,Zitvogel L,Lanier LL,Yokoyama WM,Ugolini S.Innate or adaptive immunity?The example of natural killer cells.Science 2011;331:44-49[PMID:21212348 DOI:10.1126/science.1198687]
20 Lanier LL.Evolutionary struggles between NK cells and viruses.Nat Rev Immunol 2008;8:259-268[PMID:18340344 DOI:nri2276]
21 Altfeld M,Fadda L,Frleta D,Bhardwaj N.DCs and NK cells:critical effectors in the immune response to HIV-1.Nat Rev Immunol 2011;11:176-186[PMID:21350578 DOI:10.1038/nri2935]
22 Caligiuri MA.Human natural killer cells.Blood 2008;112:461-469[PMID:18650461 DOI:112/3/461]
23 Lodoen MB,Lanier LL.Natural killer cells as an initial defense against pathogens.Curr Opin Immunol 2006;18:391-398[PMID:16765573]
24 Lee SH,Miyagi T,Biron CA.Keeping NK cells in highly regulated antiviral warfare.Trends Immunol 2007;28:252-259[PMID:17466596 DOI:10.1016/j.it.2007.04.001]
25 Lanier LL.Up on the tightrope:natural killer cell activation and inhibition.Nat Immunol 2008;9:495-502[PMID:18425106 DOI:ni1581]
26 Lanier LL.NK cell recognition.Annu Rev Immunol 2005;2 3:2 2 5-2 7 4[P M I D:1 5 7 7 1 5 7 1 D O I:1 0.11 4 6/a n n u r e v.immunol.23.021704.115526]
27 Vivier E,Tomasello E,Baratin M,Walzer T,Ugolini S.Functions of natural killer cells.Nat Immunol 2008;9:503-510[PMID:18425107 DOI:ni1582]
28 Cooper MA,Fehniger TA,Caligiuri MA.The biology of human natural killer-cell subsets.Trends Immunol 2001;22:633-640[PMID:11698225 DOI:S1471-4906(01)02060-9]
29 Cooper MA,Fehniger TA,Turner SC,Chen KS,Ghaheri BA,Ghayur T,Carson WE,Caligiuri MA.Human natural killer cells:a unique innate immunoregulatory role for the CD56(bright)subset.Blood 2001;97:3146-3151[PMID:11342442]
30 Doherty DG,O’Farrelly C.Innate and adaptive lymphoid cells in the human liver.Immunol Rev 2000;174:5-20[PMID:10807503]
31 Gao B,Radaeva S,Park O.Liver natural killer and natural killer T cells:immunobiology and emerging roles in liver diseases.J Leukoc Biol 2009;86:513-528[PMID:19542050 DOI:JLB.0309135]
32 Bonorino P,Ramzan M,Camous X,Dufeu-Duchesne T,Thélu MA,Sturm N,Dariz A,Guillermet C,Pernollet M,Zarski JP,Marche PN,Leroy V,Jouvin-Marche E.Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.J Hepatol 2009;51:458-467[PMID:19596474DOI:10.1016/j.jhep.2009.05.030]
33 Morishima C,Paschal DM,Wang CC,Yoshihara CS,Wood BL,Yeo AE,Emerson SS,Shuhart MC,Gretch DR.Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing.Hepatology 2006;43:573-580[PMID:16496327 DOI:10.1002/hep.21073]
34 Oliviero B,Varchetta S,Paudice E,Michelone G,Zaramella M,Mavilio D,De Filippi F,Bruno S,Mondelli MU.Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis Cvirus infections.Gastroenterology 2009;137:1151-160,1151-160,[PMID:19470388 DOI:10.1053/j.gastro.2009.05.047]
35 Grégoire C,Chasson L,Luci C,Tomasello E,Geissmann F,Vivier E,Walzer T.The trafficking of natural killer cells.Immunol Rev 2007;220:169-182[PMID:17979846 DOI:10.1111/j.1600-065X.2007.00563.x]
36 Golden-Mason L,Rosen HR.Natural killer cells:primary target for hepatitis C virus immune evasion strategies?Liver Transpl2006;12:363-372[PMID:16498647 DOI:10.1002/lt.20708]
37 Crotta S,Stilla A,Wack A,D’Andrea A,Nuti S,D’Oro U,Mosca M,Filliponi F,Brunetto RM,Bonino F,Abrignani S,Valiante NM.Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.J Exp Med 2002;195:35-41[PMID:11781363]
38 Tseng CT,Klimpel GR.Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.J Exp Med2002;195:43-49[PMID:11781364]
39 Herzer K,Falk CS,Encke J,Eichhorst ST,Ulsenheimer A,Seliger B,Krammer PH.Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.J Virol 2003;77:8299-8309[PMID:12857899]
40 Tardif KD,Siddiqui A.Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells.J Virol 2003;77:11644-11650[PMID:14557650]
41 Moradpour D,Grabscheid B,Kammer AR,Schmidtke G,Groettrup M,Blum HE,Cerny A.Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.Hepatology 2001;33:1282-1287[PMID:11343257 DOI:S0270-9139(01)30790-5]
42 Yang DR,Zhu HZ.Hepatitis C virus and antiviral innate immunity:who wins at tug-of-war?World J Gastroenterol 2015;21:3786-3800[PMID:25852264 DOI:10.3748/wjg.v21.i13.3786]
43 Billerbeck E,de Jong Y,Dorner M,de la Fuente C,Ploss A.Animal models for hepatitis C.Curr Top Microbiol Immunol 2013;369:49-86[PMID:23463197 DOI:10.1007/978-3-642-27340-7_3]
44 Lindenbach BD,Evans MJ,Syder AJ,W?lk B,Tellinghuisen TL,Liu CC,Maruyama T,Hynes RO,Burton DR,Mc Keating JA,Rice CM.Complete replication of hepatitis C virus in cell culture.Science 2005;309:623-626[PMID:15947137]
45 Wakita T,Pietschmann T,Kato T,Date T,Miyamoto M,Zhao Z,Murthy K,Habermann A,Kr?usslich HG,Mizokami M,Bartenschlager R,Liang TJ.Production of infectious hepatitis Cvirus in tissue culture from a cloned viral genome.Nat Med 2005;11:791-796[PMID:15951748]
46 Zhong J,Gastaminza P,Cheng G,Kapadia S,Kato T,Burton DR,Wieland SF,Uprichard SL,Wakita T,Chisari FV.Robust hepatitis C virus infection in vitro.Proc Natl Acad Sci USA 2005;102:9294-9299[PMID:15939869]
47 Crotta S,Brazzoli M,Piccioli D,Valiante NM,Wack A.Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.J Hepatol 2010;52:183-190[PMID:20015567]
48 Yoon JC,Shiina M,Ahlenstiel G,Rehermann B.Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.Hepatology 2009;49:12-21[PMID:19085909 DOI:10.1002/hep.22624]
49 Yoon JC,Lim JB,Park JH,Lee JM.Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.J Virol 2011;85:12557-12569[PMID:21937646 DOI:10.1128/JVI.00838-11]
50 Holder KA,Stapleton SN,Gallant ME,Russell RS,Grant MD.Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.J Immunol 2013;191:3308-3318[PMID:23960237 DOI:10.4049/jimmunol.1300164]
51 Stegmann KA,Bj?rkstr?m NK,Ciesek S,Lunemann S,Jaroszewicz J,Wiegand J,Malinski P,Dustin LB,Rice CM,Manns MP,Pietschmann T,Cornberg M,Ljunggren HG,Wedemeyer H.Interferonα-stimulated natural killer cells from patients with acute hepatitis C virus(HCV)infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.JInfect Dis 2012;205:1351-1362[PMID:22457290 DOI:10.1093/infdis/jis210]
52 Stegmann KA,Bj?rkstr?m NK,Veber H,Ciesek S,Riese P,Wiegand J,Hadem J,Suneetha PV,Jaroszewicz J,Wang C,Schlaphoff V,Fytili P,Cornberg M,Manns MP,Geffers R,Pietschmann T,Guzmán CA,Ljunggren HG,Wedemeyer H.Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.Gastroenterology2010;138:1885-1897[PMID:20334827 DOI:10.1053/j.gastro.2010.01.051]
53 Biron CA,Nguyen KB,Pien GC,Cousens LP,Salazar-Mather TP.Natural killer cells in antiviral defense:function and regulation by innate cytokines.Annu Rev Immunol 1999;17:189-220[PMID:10358757 DOI:10.1146/annurev.immunol.17.1.189]
54 Hart OM,Athie-Morales V,O’Connor GM,Gardiner CM.TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.J Immunol 2005;175:1636-1642[PMID:16034103]
55 Newman KC,Riley EM.Whatever turns you on:accessory-celldependent activation of NK cells by pathogens.Nat Rev Immunol2007;7:279-291[PMID:17380157 DOI:10.1038/nri2057]
56 Cooper MA,Fehniger TA,Fuchs A,Colonna M,Caligiuri MA.NK cell and DC interactions.Trends Immunol 2004;25:47-52[PMID:14698284]
57 Velazquez VM,Hon H,Ibegbu C,Knechtle SJ,Kirk AD,Grakoui A.Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.Hepatology 2012;56:2071-2081[PMID:22711645 DOI:10.1002/hep.25904]
58 Michel T,Hentges F,Zimmer J.Consequences of the crosstalk between monocytes/macrophages and natural killer cells.Front Immunol 2012;3:403[PMID:23316194 DOI:10.3389/fimmu.2012.00403]
59 Lau DT,Negash A,Chen J,Crochet N,Sinha M,Zhang Y,Guedj J,Holder S,Saito T,Lemon SM,Luxon BA,Perelson AS,Gale M.Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype1 infection.Gastroenterology 2013;144:402-413.e12[PMID:23123437 DOI:10.1053/j.gastro.2012.10.044]
60 Tu Z,Bozorgzadeh A,Pierce RH,Kurtis J,Crispe IN,Orloff MS.TLR-dependent cross talk between human Kupffer cells and NKcells.J Exp Med 2008;205:233-244[PMID:18195076 DOI:10.1084/jem.20072195]
61 Zhang S,Saha B,Kodys K,Szabo G.IFN-γproduction by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.J Hepatol 2013;59:442-449[PMID:23665181 DOI:10.1016/j.jhep.2013.04.022]
62 Marukian S,Jones CT,Andrus L,Evans MJ,Ritola KD,Charles ED,Rice CM,Dustin LB.Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.Hepatology2008;48:1843-1850[PMID:19003912 DOI:10.1002/hep.22550]
63 Dental C,Florentin J,Aouar B,Gondois-Rey F,Durantel D,Baumert TF,Nunes JA,Olive D,Hirsch I,Stranska R.Hepatitis Cvirus fails to activate NF-κB signaling in plasmacytoid dendritic cells.J Virol 2012;86:1090-1096[PMID:22090103 DOI:10.1128/JVI.05444-11]
64 Takahashi K,Asabe S,Wieland S,Garaigorta U,Gastaminza P,Isogawa M,Chisari FV.Plasmacytoid dendritic cells sense hepatitis C virus-infected cells,produce interferon,and inhibit infection.Proc Natl Acad Sci USA 2010;107:7431-7436[PMID:20231459DOI:10.1073/pnas.1002301107]
65 Zhang XA,Huang C.Tetraspanins and cell membrane tubular structures.Cell Mol Life Sci 2012;69:2843-2852[PMID:22450717 DOI:10.1007/s00018-012-0954-0]
66 Dreux M,Garaigorta U,Boyd B,Décembre E,Chung J,WhittenBauer C,Wieland S,Chisari FV.Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.Cell Host Microbe 2012;12:558-570[PMID:23084922 DOI:10.1016/j.chom.2012.08.010]
67 Serti E,Werner JM,Chattergoon M,Cox AL,Lohmann V,Rehermann B.Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis Cvirus replication.Gastroenterology 2014;147:209-220.e3[PMID:24685721 DOI:10.1053/j.gastro.2014.03.046]
68 Sène D,Levasseur F,Abel M,Lambert M,Camous X,Hernandez C,Pène V,Rosenberg AR,Jouvin-Marche E,Marche PN,Cacoub P,Caillat-Zucman S.Hepatitis C virus(HCV)evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.PLo S Pathog 2010;6:e1001184[PMID:21085608 DOI:10.1371/journal.ppat.1001184]
69 Khakoo SI,Thio CL,Martin MP,Brooks CR,Gao X,Astemborski J,Cheng J,Goedert JJ,Vlahov D,Hilgartner M,Cox S,Little AM,Alexander GJ,Cramp ME,O’Brien SJ,Rosenberg WM,Thomas DL,Carrington M.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.Science 2004;305:872-874[PMID:15297676 DOI:10.1126/science.1097670]
70 Cheent K,Khakoo SI.Natural killer cells and hepatitis C:action and reaction.Gut 2011;60:268-278[PMID:20876777 DOI:10.1136/gut.2010.212555]
71 Bengsch B,Thimme R,Blum HE.Role of host genetic factors in the outcome of hepatitis C virus infection.Viruses 2009;1:104-125[PMID:21994541 DOI:10.3390/v1020104]
72 Ahlenstiel G,Martin MP,Gao X,Carrington M,Rehermann B.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.J Clin Invest 2008;118:1017-1026[PMID:18246204 DOI:10.1172/JCI32400]
73 Amadei B,Urbani S,Cazaly A,Fisicaro P,Zerbini A,Ahmed P,Missale G,Ferrari C,Khakoo SI.Activation of natural killer cells during acute infection with hepatitis C virus.Gastroenterology2010;138:1536-1545[PMID:20080094 DOI:10.1053/j.gastro.2010.01.006]
74 Werner JM,Heller T,Gordon AM,Sheets A,Sherker AH,Kessler E,Bean KS,Stevens M,Schmitt J,Rehermann B.Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.Hepatology 2013;58:1621-1631[PMID:23463364 DOI:10.1002/hep.26353]
75 Pelletier S,Drouin C,Bédard N,Khakoo SI,Bruneau J,Shoukry NH.Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.J Hepatol 2010;53:805-816[PMID:20688412 DOI:10.1016/j.jhep.2010.05.013]
76 Kokordelis P,Kr?mer B,K?rner C,Boesecke C,Voigt E,Ingiliz P,Gl?ssner A,Eisenhardt M,Wolter F,Kaczmarek D,Nischalke HD,Rockstroh JK,Spengler U,Nattermann J.An effective interferongamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.Hepatology 2014;59:814-827[PMID:24382664 DOI:10.1002/hep.26782]
77 Ahlenstiel G,Titerence RH,Koh C,Edlich B,Feld JJ,Rotman Y,Ghany MG,Hoofnagle JH,Liang TJ,Heller T,Rehermann B.Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.Gastroenterology 2010;138:325-35.e1-2[PMID:19747917 DOI:10.1053/j.gastro.2009.08.066]
78 Golden-Mason L,Madrigal-Estebas L,Mc Grath E,Conroy MJ,Ryan EJ,Hegarty JE,O’Farrelly C,Doherty DG.Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.Gut 2008;57:1121-1128[PMID:18372499 DOI:10.1136/gut.2007.130963]
79 Jinushi M,Takehara T,Tatsumi T,Kanto T,Miyagi T,Suzuki T,Kanazawa Y,Hiramatsu N,Hayashi N.Negative regulation of NKcell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.J Immunol 2004;173:6072-6081[PMID:15528343]
80 Nattermann J,Feldmann G,Ahlenstiel G,Langhans B,Sauerbruch T,Spengler U.Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.Gut 2006;55:869-877[PMID:16322112 DOI:10.1136/gut.2005.076463]
81 Edlich B,Ahlenstiel G,Zabaleta Azpiroz A,Stoltzfus J,Noureddin M,Serti E,Feld JJ,Liang TJ,Rotman Y,Rehermann B.Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis Cpatients.Hepatology 2012;55:39-48[PMID:21898483 DOI:10.1002/hep.24628]
82 Miyagi T,Gil MP,Wang X,Louten J,Chu WM,Biron CA.High basal STAT4 balanced by STAT1 induction to control type1 interferon effects in natural killer cells.J Exp Med 2007;204:2383-2396[PMID:17846149 DOI:10.1084/jem.20070401]
83 Miyagi T,Takehara T,Nishio K,Shimizu S,Kohga K,Li W,Tatsumi T,Hiramatsu N,Kanto T,Hayashi N.Altered interferonalpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.J Hepatol 2010;53:424-430[PMID:20554341 DOI:10.1016/j.jhep.2010.03.018]
84 Nguyen KB,Cousens LP,Doughty LA,Pien GC,Durbin JE,Biron CA.Interferon alpha/beta-mediated inhibition and promotion of interferon gamma:STAT1 resolves a paradox.Nat Immunol 2000;1:70-76[PMID:10881178 DOI:10.1038/76940]
85 Kr?mer B,K?rner C,Kebschull M,Gl?ssner A,Eisenhardt M,Nischalke HD,Alexander M,Sauerbruch T,Spengler U,Nattermann J.Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.Hepatology2012;56:1201-1213[PMID:22532190 DOI:10.1002/hep.25804]
86 Gl?ssner A,Eisenhardt M,Kr?mer B,K?rner C,Coenen M,Sauerbruch T,Spengler U,Nattermann J.NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-,Fas L-and NKG2D-dependent manner.Lab Invest 2012;92:967-977[PMID:22449797 DOI:10.1038/labinvest.2012.54]
87 Pembroke T,Christian A,Jones E,Hills RK,Wang EC,Gallimore AM,Godkin A.The paradox of NKp46+natural killer cells:drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferonαtreatment.Gut 2014;63:515-524[PMID:23665989 DOI:10.1136/gutjnl-2013-304472]
88 De Maria A,Fogli M,Mazza S,Basso M,Picciotto A,Costa P,Congia S,Mingari MC,Moretta L.Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.Eur J Immunol 2007;37:445-455[PMID:17273991 DOI:10.1002/eji.200635989]
89 Varchetta S,Mele D,Mantovani S,Oliviero B,Cremonesi E,Ludovisi S,Michelone G,Alessiani M,Rosati R,Montorsi M,Mondelli MU.Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.Hepatology 2012;56:841-849[PMID:22431186 DOI:10.1002/hep.25723]
90 Wang JM,Cheng YQ,Shi L,Ying RS,Wu XY,Li GY,Moorman JP,Yao ZQ.KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.J Virol 2013;87:11626-11636[PMID:23966413 DOI:10.1128/JVI.01515-13]
91 Gonzalez VD,Landay AL,Sandberg JK.Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.Clin Immunol 2010;135:12-25[PMID:20100670 DOI:10.1016/j.clim.2009.12.005]
92 Hernandez MD,Sherman KE.HIV/hepatitis C coinfection natural history and disease progression.Curr Opin HIVAIDS 2011;6:478-482[PMID:22001892 DOI:10.1097/COH.0b013e32834bd365]
93 Gl?ssner A,Eisenhardt M,Kokordelis P,Kr?mer B,Wolter F,Nischalke HD,Boesecke C,Sauerbruch T,Rockstroh JK,Spengler U,Nattermann J.Impaired CD4?T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.J Hepatol 2013;59:427-433[PMID:23665286 DOI:10.1016/j.jhep.2013.04.029]
94 Knapp S,Warshow U,Hegazy D,Brackenbury L,Guha IN,Fowell A,Little AM,Alexander GJ,Rosenberg WM,Cramp ME,Khakoo SI.Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.Hepatology2010;51:1168-1175[PMID:20077564 DOI:10.1002/hep.23477]
95 Suppiah V,Gaudieri S,Armstrong NJ,O’Connor KS,Berg T,Weltman M,Abate ML,Spengler U,Bassendine M,Dore GJ,Irving WL,Powell E,Hellard M,Riordan S,Matthews G,Sheridan D,Nattermann J,Smedile A,Müller T,Hammond E,Dunn D,Negro F,Bochud PY,Mallal S,Ahlenstiel G,Stewart GJ,George J,Booth DR.IL28B,HLA-C,and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort:a cross-sectional study.PLo SMed 2011;8:e1001092[PMID:21931540 DOI:10.1371/journal.pmed.1001092]
96 Kaser A,Enrich B,Ludwiczek O,Vogel W,Tilg H.Interferonalpha(IFN-alpha)enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.Clin Exp Immunol 1999;118:71-77[PMID:10540162]
97 Bozzano F,Picciotto A,Costa P,Marras F,Fazio V,Hirsch I,Olive D,Moretta L,De Maria A.Activating NK cell receptor expression/function(NKp30,NKp46,DNAM-1)during chronic viraemic HCV infection is associated with the outcome of combined treatment.Eur J Immunol 2011;41:2905-2914[PMID:21695691DOI:10.1002/eji.201041361]
98 Conry SJ,Meng Q,Hardy G,Yonkers NL,Sugalski JM,Hirsch A,Davitkov P,Compan A,Falck-Ytter Y,Blanton RE,Rodriguez B,Harding CV,Anthony DD.Genetically associated CD16(+)56(-)natural killer cell interferon(IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.J Infect Dis 2012;205:1131-1141[PMID:22351942 DOI:10.1093/infdis/jis027]
99 Ahlenstiel G,Edlich B,Hogdal LJ,Rotman Y,Noureddin M,Feld JJ,Holz LE,Titerence RH,Liang TJ,Rehermann B.Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.Gastroenterology 2011;141:1231-1239[PMID:21741920 DOI:10.1053/j.gastro.2011.06.069]
100 Oliviero B,Mele D,Degasperi E,Aghemo A,Cremonesi E,Rumi MG,Tinelli C,Varchetta S,Mantovani S,Colombo M,Mondelli MU.Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.J Hepatol 2013;59:38-44[PMID:23499727 DOI:10.1016/j.jhep.2013.03.003]
101 He XS,Ji X,Hale MB,Cheung R,Ahmed A,Guo Y,Nolan GP,Pfeffer LM,Wright TL,Risch N,Tibshirani R,Greenberg HB.Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.Hepatology2006;44:352-359[PMID:16871572 DOI:10.1002/hep.21267]
102 Sarasin-Filipowicz M,Oakeley EJ,Duong FH,Christen V,Terracciano L,Filipowicz W,Heim MH.Interferon signaling and treatment outcome in chronic hepatitis C.Proc Natl Acad Sci USA 2008;105:7034-7039[PMID:18467494 DOI:10.1073/pnas.0707882105]
103 Ge D,Fellay J,Thompson AJ,Simon JS,Shianna KV,Urban TJ,Heinzen EL,Qiu P,Bertelsen AH,Muir AJ,Sulkowski M,Mc Hutchison JG,Goldstein DB.Genetic variation in IL28Bpredicts hepatitis C treatment-induced viral clearance.Nature2009;461:399-401[PMID:19684573 DOI:10.1038/nature08309]
104 Suppiah V,Moldovan M,Ahlenstiel G,Berg T,Weltman M,Abate ML,Bassendine M,Spengler U,Dore GJ,Powell E,Riordan S,Sheridan D,Smedile A,Fragomeli V,Müller T,Bahlo M,Stewart GJ,Booth DR,George J.IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.Nat Genet 2009;41:1100-1104[PMID:19749758 DOI:10.1038/ng.447]
105 Tanaka Y,Nishida N,Sugiyama M,Kurosaki M,Matsuura K,Sakamoto N,Nakagawa M,Korenaga M,Hino K,Hige S,Ito Y,Mita E,Tanaka E,Mochida S,Murawaki Y,Honda M,Sakai A,Hiasa Y,Nishiguchi S,Koike A,Sakaida I,Imamura M,Ito K,Yano K,Masaki N,Sugauchi F,Izumi N,Tokunaga K,Mizokami M.Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.Nat Genet 2009;41:1105-1109[PMID:19749757 DOI:10.1038/ng.449]
106 Naggie S,Osinusi A,Katsounas A,Lempicki R,Herrmann E,Thompson AJ,Clark PJ,Patel K,Muir AJ,Mc Hutchison JG,Schlaak JF,Trippler M,Shivakumar B,Masur H,Polis MA,Kottilil S.Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients:impaired viral kinetics and therapeutic response.Hepatology 2012;56:444-454[PMID:22331604 DOI:10.1002/hep.25647]
107 Golden-Mason L,Bambha KM,Cheng L,Howell CD,Taylor MW,Clark PJ,Afdhal N,Rosen HR.Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C.Hepatology 2011;54:1559-1569[PMID:21983945 DOI:10.1002/hep.24556]
108 Kr?mer B,Eisenhardt M,Gl?ssner A,K?rner C,Sauerbruch T,Spengler U,Nattermann J.Do lambda-IFNs IL28A and IL28Bact on human natural killer cells?Proc Natl Acad Sci USA 2011;108:E519-E520;author reply E521-E522[PMID:21825163 DOI:10.1073/pnas.1108850108]
109 O’Connor KS,Ahlenstiel G,Suppiah V,Schibeci S,Ong A,Leung R,van der Poorten D,Douglas MW,Weltman MD,Stewart GJ,Liddle C,George J,Booth DR.IFNL3 mediates interaction between innate immune cells:Implications for hepatitis C virus pathogenesis.Innate Immun 2014;20:598-605[PMID:24045339DOI:10.1177/1753425913503385]
110 Dring MM,Morrison MH,Mc Sharry BP,Guinan KJ,Hagan R,O’Farrelly C,Gardiner CM.Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.Proc Natl Acad Sci USA 2011;108:5736-5741[PMID:21402922 DOI:10.1073/pnas.1016358108]
111 Shimoda S,Sumida K,Iwasaka S,Hisamoto S,Tanimoto H,Nomura H,Dohmen K,Takahashi K,Kawano A,Ogawa E,Furusyo N,Akashi K,Hayashi J.Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections.Hepat Res Treat 2013;2013:374196[PMID:23997950 DOI:10.1155/2013/374196]
112 Anthony DD,Conry SJ,Medvik K,Sandhya Rani MR,FalckYtter Y,Blanton RE,Lederman MM,Rodriguez B,Landay AL,Sandberg JK.Baseline levels of soluble CD14 and CD16+56-natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.JInfect Dis 2012;206:969-973[PMID:22782948 DOI:10.1093/infdis/jis434]
113 Serti E,Chepa-Lotrea X,Kim YJ,Keane M,Fryzek N,Liang TJ,Ghany M,Rehermann B.Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.Gastroenterology 2015;149:190-200.e2[PMID:25754160 DOI:10.1053/j.gastro.2015.03.004]
114 Kolykhalov AA,Agapov EV,Blight KJ,Mihalik K,Feinstone SM,Rice CM.Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.Science 1997;277:570-574[PMID:9228008]
115 Lindenbach BD,Meuleman P,Ploss A,Vanwolleghem T,Syder AJ,Mc Keating JA,Lanford RE,Feinstone SM,Major ME,Leroux-Roels G,Rice CM.Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.Proc Natl Acad Sci USA 2006;103:3805-3809[PMID:16484368 DOI:10.1073/pnas.0511218103]
116 Farquhar MJ,Mc Keating JA.Primary hepatocytes as targets for hepatitis C virus replication.J Viral Hepat 2008;15:849-854[PMID:19087224 DOI:JVH1051]
117 Wieland S,Makowska Z,Campana B,Calabrese D,Dill MT,Chung J,Chisari FV,Heim MH.Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver.Hepatology 2014;59:2121-2130[PMID:24122862 DOI:10.1002/hep.26770]
118 Dorner M,Horwitz JA,Robbins JB,Barry WT,Feng Q,Mu K,Jones CT,Schoggins JW,Catanese MT,Burton DR,Law M,Rice CM,Ploss A.A genetically humanized mouse model for hepatitis C virus infection.Nature 2011;474:208-211[PMID:21654804]
119 Dorner M,Ploss A.Deconstructing hepatitis C virus infection in humanized mice.Ann N Y Acad Sci 2011;1245:59-62[PMID:22211981]